Adjuvants QS-21 data

RIBI (Hamilton, Mont.) reported that its MPL adjuvant incorporated with SmithKline Beecham's influenza vaccine, along with Cambridge Biotech's QS-21adjuvant, enhanced lymphoproliferation and production of interferon-gamma.

The MPL/QS-21 combination also stimulated higher rates of seroconversion to a protective antibody level, compared to QS-21 alone or antigen without any adjuvant. ...